J&J CEO’s Lower-Risk Alternative to Acquisitions (Wall Street Journal)
FDA doesn’t act on post-marketing data (Fierce Pharma)
Novel diagnostic test for embryo viability developed (MedWire News)
Tweens challenged by grown-up malady: Breast cancer (CNN Health)
Stubborn asthma may signal poor use of Meds (24 Medica)
Drug stocks edge higher; BioCryst soars (Market Watch)
Q3/2009: Merck KGaA Revenues Increase by 2.7% to € 1.9 Billion (Pharma Live)
SUBSCRIBE